Ulcerative colitis and cytomegaloviral esophagitis: two diseases, two randomized, controlled trials.
Surawicz
C M
CM
University of Washington School of Medicine, Harborview Medical Center, Box 359773, 325 Ninth Avenue, Seattle, WA 98104, USA.
D000998:Antiviral Agents / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D003586:Cytomegalovirus Infections / Q000175:diagnosis / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D004941:Esophagitis / Q000175:diagnosis / Q000188:drug therapy* / Q000821:virology*; D005260:Female; D006801:Humans; D008297:Male; D019804:Mesalamine / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
D000998:Antiviral Agents; D019804:Mesalamine; D002939:Ciprofloxacin; D011241:Prednisone